Skip to content

UW Global navigation

Local navigation

Site contents menu

University of Wisconsin Stem Cell & Regenerative Medicine Center

Faculty Trainers

Currently, UW–Madison has more than 40 faculty members working in many disciplines engaged in stem cell research. The work ranges from basic science in important animal models such as nonhuman primates to studies of human embryonic, adult and cancer stem cells. The ultimate goals of this research are to help develop a full basic understanding of stem cells, their properties, how they work and how they might be applied to treat human disease.

Caroline Alexander
Oncology
Mouse models of breast cancer; understanding the changes of epithelial cell growth control that accompany pre-neoplasia and progression. Breast stem cells and their role in tumor initiation.
 
Lynn Allen-Hoffmann
Pathology and Laboratory Medicine
Tissue engineered models of human skin; dissecting the proximal tissue interactions important for AhR ligand toxicity in human stratified squamous epithelia. Differentiation of keratinocytes from human embryonic stem (ES) cells.
 
David Beebe
Biomedical Engineering
Creating systems that allow precise control of the cellular microenvironment to both study and control stem cell fate. We work with both hES cells and mammary epithelial progenitor cells with collaborators T. Kamp and C. Alexander.
 
Emery Bresnick
Pharmacology
Molecular mechanisms controlling the differentiation of blood cells from hematopoietic stem cells (HSCs), including: (i) transcriptional mechanisms that control the synthesis of key regulators of HSCs, and (ii) how chromatin domains assemble and are regulated in stem cells vs. differentiated cells.
 
Alta Charo
Law School
Legal and policy issues in biomedical research. Committee Liaison for National Academy of Sciences, Ethics Guidelines for Embryonic Stem Cell Research. Member of the ethics standards working group of the California Institute for Regenerative Medicine.
 
Juan DePablo
Chemical and Biochemical Engineering
Preservation and long term storage of mammalian cells, with a particular emphasis on human ES cells. Molecular thermodynamics and statistical mechanics.
 
Ian Duncan
School of Veterinary Medicine
Strategies to myelinate or remyelinate the brain in animal models of human genetic or acquired myelin disorders. Human neural stem cells and their potential differentiation into the myelin producing cell of the CNS, the oligodendrocyte. Methods for promoting widespread dissemination or migration of cells upon transplantation.
 
Norman Fost
Medical History and Bioethics
As Chair of the Health Sciences IRB and the University’s Bioethics Advisory Committee, Dr. Fost has played a central role in developing the conditions of approval for human ES cell research at UW–Madison, including an extensive review of the ethical, legal, regulatory and policy issues affecting stem cell research Dr. Fost has been a member of the AAAS Working Group on Stem Cell Research.
 
David Gamm
Ophthalmology and Visual Sciences
Culture, differentiation, and transplantation of human retinal stem/progenitor cells and retinal pigment epithelial cells.
 
Ted Golos
Obstetrics and Gynecology
Use of nonhuman primate models, human clinical materials, and ES cells to examine questions of placental biology and maternal-fetal interactions.
 
Peiman Hematti
Medicine
Hematopoietic differentiation of human and non-human primate ES cells. Development of the rhesus macaque as a pre-clinical model for evaluation of novel gene and stem cell therapies. Hematopoietic stem cell expansion for transplantation.
 
Linda Hogle
Medical History and Bioethics
Social, ethical and legal/regulatory issues in emerging biomedical technologies. Analysis of emerging regulatory pathways for novel biological and combination products, and organizational and education concerns for future generations of interdisciplinary researchers.
 
Tim Kamp
Medicine
Mechanisms controlling differentiation of human ES cells into distinct types of cardiomyocytes and electrophysiological properties of ES cell-derived cardiomyocytes; stem cell-based therapies for myocardial repair and regeneration in cardiac disease models.
 
Judith Kimble
Biochemistry
Stem cell controls in the nematode Caenorhabditis elegans. Molecular mechanisms by which the stem cell niche regulates the balance between stem cells and differentiation, and investigation of whether mechanisms regulating stem cells in C. elegans are conserved in humans.
 
John Kuo
Neurosurgery
Understanding molecular mechanisms of tumorigenesis via brain tumor stem cells and associated in vitro and in vivo tumor models; developing novel diagnostic and therapeutic strategies for benign and malignant brain tumors.
 
Youngsook Lee
Anatomy
Molecular mechanisms controlling normal cardiovascular differentiation and development. We take both in vivo and in vitro approaches; 1) To identify novel factors that are critical for normal cardiovascular development, we generate knock out mice to analyze the phenotype. 2) Using human ES cells, we examine molecular pathways to enhance cardiomyocyte generation.
 
Gary Lyons
Anatomy
ES cells and cardiac myocyte differentiation in vivo and in vitro. Genetic approaches to unraveling the complex molecular mechanisms involved in normal heart and vascular development that go awry in congenital heart disease. We also culture mouse, rhesus and human ES cells to produce purified cultures of cardiac myocytes.
 
Clark Miller
Lafollette School of Public Affairs
Science and technology policy, across a broad range of fields from global environmental change to nanotechnology and stem cells.
 
Bill Murphy
Biomedical Engineering
Delivery of developmental signals to influence stem cell activity. Development of biomaterials for tissue regeneration (tissue engineering). Novel approaches to drug delivery and gene therapy. Creation of novel materials using bioinspired approaches.
 
Jon Odorico
Surgery
Developing novel stem cell-based strategies for treating diabetes; stem cell biology and differentiation; pancreas and islet cell transplantation.
 
Sean Palecek
Chemical and Biological Engineering
Effects of stresses on growth and differentiation of human ES cells. Improving viability of human ES cells during cryopreservation. We collaborate with Lynn Allen-Hoffmann’s group to study human ES cell differentiation into keratinocytes with the long term goal of generating skin product.
 
Amish N. Raval
Cardiovascular Medicine
Bench to bedside translation of cell therapy. Focus on novel local cell delivery, labeling and sensitive imaging methods for potential use in human trials. Development of early phase human trials currently using adult progenitors to treat severe cardiac and peripheral arterial disease.
 
Aimen Shaaban
Surgery
Fetal stem cell transplantation. Study of the homing, engraftment and differentiation of pre-natally transplanted embryonic stem cell-derived hematopoietic stem cells. Examination of the mechanisms of long-term immunologic tolerance to pre-natally transplanted stem cells.
 
Igor Slukvin
Pathology and Laboratory Medicine
Differentiation of human ES cells into hematopoietic progenitors and mature blood cells in order to understand molecular mechanisms of early hematopoietic differentiation and to provide a novel source of cells for bone marrow transplantation, transfusion and cancer immunotherapy.
 
Clive Svendsen
Waisman Center
Neurobiology and neural stem cells, including (i) the molecular mechanisms underlying new neuron production from neural stem cells (ii) the use of human neural stem cells to model neurological diseases and (iii) the transplantation of genetically modified neural stem cells in models of human neurological disease including Parkinson’s and ALS.
 
James Thomson
Genome Center
Understanding how human embryonic stem (ES) cells choose between self-renewal, death, and differentiation to specific lineages. Differentiation of human ES cells to early embryonic lineages.
 
Su-Chun Zhang
Waisman Center
Neural lineage differentiation of ES cells. Use of ES cells as a tool to understand early human neural development. Investigating the potential of stem cell derivatives in animal models of neurological conditions.